Endoscope Reprocessing Market Size & Growth Forecast 2027–2036, By Segments (End-use, Product), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Endoscope Reprocessing Market size was valued at USD 2.4 billion in 2026 and is projected to grow at a 6.46% CAGR from 2027 to 2036, reaching USD 4.49 billion by 2036. The industry revenue for 2027 is estimated at USD 2.53 billion.

• Base Year Value (2026): USD 2.4 billion
• CAGR (2027-2036): 6.46%
• Forecast Year Value (2036): USD 4.49 billion
• Historical Data Period: 2022-2026
• Largest Region: North America
• Forecast Period: 2027-2036

Endoscope Reprocessing Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America leads through established reprocessing protocols, high procedural volumes, and compliance-driven investments in advanced disinfection and traceability systems.
  • Asia Pacific is expanding at a 10.62% CAGR as healthcare infrastructure grows, endoscopic procedures increase, and hospitals adopt standardized reprocessing practices.

• Segment Momentum:

  • High-Level Disinfectants & Test Strips captured a 32.11% share in 2026 because every reprocessing cycle requires disinfection verification and chemical effectiveness checks, creating steady and recurring demand across healthcare settings.
  • Automated Endoscope Reprocessors are expanding quickly as healthcare providers seek standardized workflows, reduced manual handling, and more consistent reprocessing practices to support higher procedure volumes and compliance requirements.

• Market Expansion Drivers:

  • Rising infection risks from contaminated endoscopes increasing demand for advanced reprocessing solutions.
  • Growing preference for minimally invasive surgeries driving higher endoscope utilization and sterilization needs.
  • Expansion of ambulatory surgical centers strengthening standardized endoscope sterilization and compliance adoption.

• Leading Market Participants:

  Key players in the endoscope reprocessing market include Olympus Corporation (Japan), STERIS plc (Cantel Medical Corp.) (Ireland), Getinge AB (Sweden), Ecolab Inc. (United States), Fortive Corporation (Advanced Sterilization Products, Inc.) (United States), Steelco S.p.A. (Italy), Shinva Medical Instrument Co., Ltd. (China), Metrex Research, LLC (United States), Belimed AG (Switzerland).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 2.4 billion
  • 2027 Estimated Market Size: USD 2.53 billion.
  • Projected Market Size: USD 4.49 billion by 2036
  • Growth Forecasts: 6.46% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Outpatient Facilities (End-use) | High-Level Disinfectants & Test Strips (Product)
  • Emerging Opportunity Segment: Outpatient Facilities (End-use) | Automated Endoscope Reprocessors (Product)

Market Growth Drivers and Industry Trends

Rising infection risks from contaminated endoscopes increasing demand for advanced reprocessing solutions

Rising infection risks associated with improperly reprocessed medical instruments will drive the endoscope reprocessing market growth as healthcare facilities strengthen cleaning, disinfection, and sterilization practices. Endoscopes contain complex channels and components that can be difficult to clean thoroughly, creating a need for specialized equipment and validated procedures that reduce contamination risks. Automated reprocessors, drying systems, leak testing equipment, and related technologies help healthcare providers establish more consistent reprocessing workflows and maintain appropriate infection-control standards.

Growing preference for minimally invasive surgeries driving higher endoscope utilization and sterilization needs

The endoscope reprocessing market is benefiting from growing adoption of minimally invasive procedures, which increases the use of reusable endoscopic equipment across diagnostic and surgical settings. These procedures can offer advantages such as smaller incisions and reduced recovery requirements, encouraging healthcare providers to expand endoscopic capabilities across multiple specialties. Higher utilization creates a corresponding need for reliable cleaning, high-level disinfection, drying, and storage processes between procedures to maintain instrument safety and operational readiness.

Expansion of ambulatory surgical centers strengthening standardized endoscope sterilization and compliance adoption

Expansion of ambulatory surgical centers will boost the endoscope reprocessing market demand as these facilities increasingly perform procedures that require reusable endoscopic instruments. Standardized reprocessing systems can help outpatient facilities establish consistent workflows despite operating with limited space and resources compared with larger hospitals. Adoption of automated cleaning and disinfection equipment, documented processing protocols, and monitoring systems supports infection-control compliance while helping surgical centers manage instrument turnaround efficiently.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising infection risks from contaminated endoscopes increasing demand for advanced reprocessing solutions	2.20%	High	North America, Europe	High	Near Term
Growing preference for minimally invasive surgeries driving higher endoscope utilization and sterilization needs	2.00%	Moderate	North America, Asia Pacific	High	Near Term
Expansion of ambulatory surgical centers strengthening standardized endoscope sterilization and compliance adoption	1.70%	High	North America, Europe	Medium	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

In the endoscope reprocessing market, North America held the largest share in 2026, supported by well-established healthcare infrastructure, stringent infection prevention practices, and widespread adoption of standardized endoscope reprocessing protocols. Healthcare facilities across the region place strong emphasis on patient safety and compliance with reprocessing requirements, encouraging investment in automated and technologically advanced systems. The increasing utilization of endoscopic procedures across diagnostic and therapeutic applications is also creating sustained demand for reliable cleaning, disinfection, and sterilization solutions, while ongoing improvements in healthcare facility infrastructure support continued market development.

Asia Pacific is expected to demonstrate the fastest growth, driven by expanding healthcare infrastructure, rising healthcare expenditure, and increasing adoption of minimally invasive diagnostic and surgical procedures. Greater awareness of healthcare-associated infection prevention is encouraging hospitals and clinics to strengthen endoscope cleaning and disinfection practices. Improvements in healthcare access, expansion of medical facilities, and increasing adoption of automated reprocessing technologies are further creating opportunities for market expansion. As healthcare providers place greater emphasis on standardized infection-control procedures, demand for efficient and reliable reprocessing solutions is gaining momentum across the region.

Key Country Insights

United States

Infection Control Innovation

The U.S. market emphasizes advanced endoscope reprocessing systems that improve infection prevention, workflow consistency, and regulatory compliance. Healthcare providers in the U.S. continue prioritizing automated solutions and traceability features to strengthen patient safety across high-volume clinical settings.

Japan

Workflow Standardization

Japan encourages endoscope reprocessing solutions that deliver consistent cleaning performance while addressing high procedural volumes. Healthcare facilities across Japan increasingly adopt automated systems that simplify compliance and reduce manual intervention in reprocessing workflows.

South Korea

Smart Hospital Integration

South Korea is expanding the use of digitally enabled endoscope reprocessing technologies within modern healthcare environments. Hospitals in South Korea favor connected equipment that enhances operational visibility, process validation, and efficient instrument management.

Germany

Precision Compliance Focus

Germany places strong emphasis on validated reprocessing protocols and equipment reliability within hospital sterilization practices. Demand in Germany supports technologies that integrate quality assurance, documentation, and efficient instrument turnaround for healthcare facilities.

France

Clinical Hygiene Enhancement

France focuses on strengthening infection prevention through dependable endoscope reprocessing practices across hospitals and specialty clinics. Healthcare providers in France seek systems that improve cleaning consistency while supporting evolving sterilization standards and operational efficiency.

Italy

Hospital Efficiency Support

Italy continues investing in endoscope reprocessing equipment that optimizes instrument availability and minimizes workflow interruptions. Healthcare organizations in Italy increasingly value automated cleaning technologies that support reliable compliance and resource utilization.

Segment Leadership and Growth Trends

 

End-use Segment Analysis: Outpatient Facilities (Largest & Fastest-Growing Segment)

Outpatient facilities segment led the endoscope reprocessing market, accounting for a 59.81% share in 2026, while also representing the fastest-growing end-use segment. Its strong position is supported by the expanding use of endoscopic procedures in ambulatory care environments, where efficient instrument turnover and consistent infection-control practices are essential. Growing emphasis on preventing healthcare-associated infections is increasing the need for reliable reprocessing workflows between procedures. The shift toward outpatient care, combined with demand for standardized cleaning, disinfection, and testing practices, is reinforcing adoption of endoscope reprocessing solutions across these facilities.

Product Segment Analysis: High-Level Disinfectants & Test Strips (Largest Segment) vs Automated Endoscope Reprocessors (Fastest-Growing Segment)

High-Level disinfectants & test strips segment held the largest share of the endoscope reprocessing market, accounting for 32.11% in 2026. These products remain fundamental to endoscope reprocessing because effective disinfection and verification are critical for maintaining patient safety and ensuring instruments are appropriately prepared for subsequent procedures. Growing awareness of infection prevention and the need for consistent quality-control practices are supporting demand for dependable disinfectants and testing solutions. Their integration into established reprocessing protocols further strengthens their importance across healthcare facilities.

Automated endoscope reprocessors represent the fastest-growing product segment, supported by increasing demand for standardized and efficient reprocessing workflows. Automated systems can reduce variability associated with manual procedures while improving process consistency and supporting healthcare facilities handling frequent endoscopic interventions. Rising emphasis on infection-control compliance, operational efficiency, and reproducible reprocessing procedures is encouraging greater adoption of automated technologies. The continued modernization of healthcare facilities is also creating favorable conditions for equipment that can streamline and strengthen endoscope reprocessing operations.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
End-use	Hospitals, Outpatient Facilities	Outpatient Facilities	Outpatient Facilities
Product	High-Level Disinfectants & Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors, Endoscope Drying, Storage, and Transport Systems, Others	High-Level Disinfectants & Test Strips	Automated Endoscope Reprocessors

Competitive Landscape and Market Positioning

Top players in the endoscope reprocessing market:

1. Olympus Corporation (Japan)

2. STERIS plc (Cantel Medical Corp.) (Ireland)

3. Getinge AB (Sweden)

4. Ecolab Inc. (United States)

5. Fortive Corporation (Advanced Sterilization Products Inc.) (United States)

6. Steelco S.p.A. (Italy)

7. Shinva Medical Instrument Co. Ltd. (China)

8. Metrex Research LLC (United States)

9. Belimed AG (Switzerland)

The endoscope reprocessing market is shaped by strict hygiene and safety requirements that are driving improvements in sterilization technologies. Advanced automated systems are being adopted to enhance reprocessing accuracy and speed. New solutions are focused on reducing turnaround time, while operational efficiency improvements are supporting better infection control and workflow optimization.

Industry Development/News

Company Name	Date	Key Development
Aspen Surgical Products	Jan-26	Aspen Surgical Products acquired Ruhof Healthcare to expand its infection prevention and instrument reprocessing portfolio. The transaction integrates enzymatic detergents, cleaning verification technologies, and specialized endoscope reprocessing solutions into Aspen's portfolio, enhancing its competitive position across sterile processing and endoscopy departments.
Nanosonics	Feb-25	Nanosonics allocated two-thirds of its USD 16.4 million research and development budget to accelerate the commercialization of CORIS, its next-generation endoscope reprocessing platform. This targeted investment underscores the company's capital deployment strategy toward capturing greater market share within the automated infection prevention segment.
Olympus Corporation & Capsa Healthcare	May-25	Olympus Corporation partnered with manufacturer Capsa Healthcare to commercialize the ScopeLocker Air endoscope drying cabinet. The product introduction directly addresses the critical final phase of the reprocessing cycle by drying internal channels, supporting compliance with strict healthcare facility infection control protocols.
Soluscope	Sep-24	Soluscope and its manufacturing operations achieved full regulatory certification under the European Union Medical Device Regulation (MDR 2017/745). This milestone enables the commercial rollout of CE-marked systems, including its Serie XS automated endoscope reprocessor, ensuring uninterrupted market access and continuous distribution across European healthcare channels.